AB
BEAT

Amalgamated Bank’s BioTelemetry, Inc. BEAT Stock Holding History

Amalgamated Bank’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,543
Closed -$400K – 1647
2020
Q4 		$400K Buy
5,543
+50
+0.9% +$2.62K 0.02% 1080
2020
Q3 		$250K Sell
5,493
-181
-3% -$7.57K 0.01% 1209
2020
Q2 		$256K Sell
5,674
-615
-10% -$27.6K 0.01% 1198
2020
Q1 		$242K Sell
6,289
-345
-5% -$15.9K 0.01% 1267
2019
Q4 		$307K Buy
6,634
+444
+7% +$19.2K 0.01% 1398
2019
Q3 		$252K Sell
6,190
-67
-1% -$2.89K 0.01% 1428
2019
Q2 		$301K Buy
6,257
+987
+19% +$51.9K 0.01% 1352
2019
Q1 		$330K Buy
5,270
+128
+2% +$8.79K 0.01% 1206
2018
Q4 		$307K Buy
+5,142
New +$309K 0.01% 1158
2018
Q3 		– Sell
-5,292
Closed -$238K – 1746
2018
Q2 		$238K Buy
+5,292
New +$211K 0.01% 1461

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Amalgamated Bank's BEAT Position: Q1 2021 in Review

Amalgamated Bank sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 5,543 shares — an estimated $400K sold.

Amalgamated Bank first reported a position in BEAT in Q2 2018 and held it in 10 quarters. The position peaked at $400K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Amalgamated Bank reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Amalgamated Bank sold 5,543 BioTelemetry, Inc. shares in Q1 2021, an estimated $400K.
  • Amalgamated Bank first reported a position in BioTelemetry, Inc. in Q2 2018 and held it in 10 quarters.
  • Amalgamated Bank's BioTelemetry, Inc. position peaked at $400K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Amalgamated Bank's 13F filing for Q1 2021, filed 13 May 2021.